The nickel market has faced challenges over the past few years due to a supply glut and weak demand. Even...
Read moreFrom established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to...
Read more(TheNewswire) TORONTO, ON, January 10, 202 5 TheNewswire – Silver Crown Royalties Inc. (‘ Silver Crown ‘, ‘ SCRi ‘,...
Read moreBrunswick Exploration Inc. ( TSX-V: BRW OTCQB: BRWXF ; FRANKFURT: 1XQ ; ‘ BRW ‘ or the ‘ Company ‘)...
Read more(TheNewswire) To receive the annual financial statements of the company for the fiscal year ended April 30, 2024, together with...
Read moreBold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce that it has received additional grab sample...
Read moreRadiopharm Theranostics (RAD:AU) has announced Lantheus increases shareholding in RAD with A$8m placement Download the PDF here. This post appeared...
Read moreFirst Helium Inc. (‘First Helium’ or the ‘Company’) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced receipt of regulatory licensing...
Read moreLode Gold Resources Inc. (TSXV: LOD) (OTCQB: LODFF) (‘Lode Gold ‘ or the ‘Company’) is pleased to announce it has...
Read moreNova Minerals (ASX:NVA,NASDAQ:NVA) announced on Wednesday (January 8) that it has reached an agreement with Nebari Gold Fund 1 to...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved